BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21924324)

  • 1. Human adrenocortical carcinoma cell lines.
    Wang T; Rainey WE
    Mol Cell Endocrinol; 2012 Mar; 351(1):58-65. PubMed ID: 21924324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies.
    Rainey WE; Bird IM; Mason JI
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):45-50. PubMed ID: 8056157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Cultures and Cell Lines for In Vitro Modeling of the Human Adrenal Cortex.
    Nanba K; Blinder AR; Rainey WE
    Tohoku J Exp Med; 2021 Apr; 253(4):217-232. PubMed ID: 33840647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.
    Penny MK; Finco I; Hammer GD
    Mol Cell Endocrinol; 2017 Apr; 445():42-54. PubMed ID: 27940298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical demonstration of cholesterol side-chain cleavage cytochrome P-450 in bovine and human adrenals.
    Sasano H; Sasano N; Okamoto M
    Pathol Res Pract; 1989 Mar; 184(3):337-42. PubMed ID: 2748459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid- and androgen-secreting black adrenocortical adenomas: unique cause of corticotropin-independent Cushing syndrome.
    Tanaka S; Tanabe A; Aiba M; Hizuka N; Takano K; Zhang J; Young WF
    Endocr Pract; 2011; 17(3):e73-8. PubMed ID: 21700558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical cell lines.
    Rainey WE; Saner K; Schimmer BP
    Mol Cell Endocrinol; 2004 Dec; 228(1-2):23-38. PubMed ID: 15541570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural pathology of the adrenal glands in Cushing's syndrome.
    Mitschke H; Saeger W
    Curr Top Pathol; 1975; 60():113-50. PubMed ID: 172295
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroendocrine differentiation of adrenocortical tumors.
    Haak HR; Fleuren GJ
    Cancer; 1995 Feb; 75(3):860-4. PubMed ID: 7828138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas.
    Sakai Y; Yanase T; Hara T; Takayanagi R; Haji M; Nawata H
    J Clin Endocrinol Metab; 1994 Jan; 78(1):36-40. PubMed ID: 8288710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
    Peri A; Luciani P; Conforti B; Baglioni-Peri S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5443-9. PubMed ID: 11701720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities.
    Samandari E; Kempná P; Nuoffer JM; Hofer G; Mullis PE; Flück CE
    J Endocrinol; 2007 Dec; 195(3):459-72. PubMed ID: 18000308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas.
    Maser-Gluth C; Reincke M; Allolio B; Schulze E
    Eur J Clin Invest; 2000 Dec; 30 Suppl 3():83-6. PubMed ID: 11281375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Androgen-producing adrenocortical adenoma. A case report].
    Nasu Y; Takeda K; Kumon H; Morioka M; Ohashi T; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):346-50. PubMed ID: 3613338
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
    Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
    J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
    Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma.
    Kitamura T; Blinder AR; Nanba K; Tsuiki M; Mishina M; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yoneyama K; Udager AM; Rainey WE; Yasoda A; Satoh-Asahara N; Tagami T
    Eur J Endocrinol; 2022 Dec; 187(6):K39-K45. PubMed ID: 36691941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidentally discovered adrenocortical adenomas are not fully nonfunctioning: immunohistochemical and dispersed adrenocortical cell study.
    Tobinaga J; Imai T; Funahashi H; Tanaka Y; Wada M; Morita T; Yamada F; Tsukamura K; Oiwa M; Kikumori T; Sasano H; Takagi H
    Endocr J; 1996 Feb; 43(1):79-86. PubMed ID: 8732456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorders of the adrenal cortex: Genetic and molecular aspects.
    Pitsava G; Maria AG; Faucz FR
    Front Endocrinol (Lausanne); 2022; 13():931389. PubMed ID: 36105398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.